The growing mortality rate due to IPF clinical syndrome in the United Kingdom, research reveals

There has been an increase in the mortality rate from 1979 to 2916 due to the idiopathic pulmonary fibrosis in the United Kingdom, according to a retrospective analysis.

It was estimated by researchers that deaths associated with idiopathic pulmonary fibrosis are near to 7 percent yearly amongst the respiratory diseases, pointing to almost 5 thousand and 5 hundred people losing their lives from the disease in the United Kingdom every year

The need for continuing investments in the strategies to halt the development of diseases was highlighted by these findings, as well as, the need for the early diagnosis. The study was published in an American Journal.

Studies conducted prior to this have shown that the incidence of idiopathic pulmonary fibrosis is growing in the United States and the United Kingdom. Death certificates were collected by the researchers at the University of Nottingham, in England and Wales from 1979 to 2016t o assess the impact of idiopathic pulmonary fibrosis burden in terms of mortality. They analyzed, as well as, identified those which were linked with what they termed as IPF clinical syndrome.

A total of 82,702 deaths were registered by the researchers between 1979 and 2016, that attributed to IPF clinical syndrome.

After doing adjustments for sex and age, the yearly increase in the incidence of IPF clinical syndrome deaths was almost 5 percent. Worth mentioning, the increase in annual mortality rates was found highest amongst people aging 85 or more and amongst men.

The researchers stated that they found a marked rise in the IPF clinical syndrome deaths from 2010 onwards, with the mortality rate related to IPF clinical syndrome being higher in 2015 than in 2010.

In spite of growing investment in the research, IPF clinical syndrome remains a major cause of respiratory mortality, and a growing concern for public health, according to the team